Study shows efficacy of roflumilast in COPD patients

11/20/2013 | Family Practice News

Researchers analyzed data on 1,400 chronic obstructive pulmonary disease patients in the U.S. and found that those who took roflumilast daily had a lower 30-day hospital readmission rate from any cause and experienced fewer monthly COPD exacerbations than those who didn't use the drug. The study was presented at the annual meeting of the American College of Chest Physicians.

View Full Article in:

Family Practice News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD